CurvaFix, Inc., a company specializing in the development of medical devices for repairing fractures in curved bones, has successfully concluded a series C financing round, raising an impressive $39 million. Leading the funding round is MVM Partners, a renowned investment firm. In addition to this exciting news, CurvaFix also announced a change in leadership, with Mark Foster taking on the role of CEO, succeeding founder Steve Dimmer.
The substantial funding secured from the series C financing will be utilized by CurvaFix to expand their efforts in treating Fragility Fractures of the Pelvis (FFP) across the United States. Furthermore, they plan to launch their innovative CurvaFix® IM Implant nationwide. MVM Partners has expressed great enthusiasm and confidence in supporting CurvaFix's growth as they target the under-served FFP segment.
Mark Foster brings a wealth of experience within the healthcare, medical device, and pharmaceutical industries to his new position as CEO of CurvaFix. His previous roles include serving as president and CEO at Trice Medical and holding key leadership positions at Smith and Nephew and Boston Scientific.